Myotonic Dystrophy - 56 Studies Found
Recruiting |
: Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy : Congenital Myotonic Dystrophy : 2017-01-25 : Other: Natural history Longitudinal disease progression |
Recruiting |
: Myotonic Dystrophy Family Registry :
: Other: Patient-entered data This registry provides patient-entered data for future clinical trial and st |
Recruiting |
: Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry :
|
Completed |
: Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients : Myotonic Dystrophy : 2010-11-15 : Other: Supine spirometry In addition to the current upright lung function evaluation we performed a supi |
Completed |
: Efficacy and Safety of DHEA for Myotonic Dystrophy : Myotonic Dystrophy : 2005-09-10 : Drug: dehydroepiandrosterone 100 and 400 mg |
Completed |
: Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 : Myotonic Dystrophy : 2011-07-20 :
|
Recruiting |
: PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study) : Myotonic Dystrophy Type 1 : 2016-03-22 |
Recruiting |
: Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ? : Myotonic Dystrophy : 2015-02-03 |
Active, not recruiting |
: Observational Prolonged Trial in Myotonic Dystrophy Type 1 : Myotonic Dystrophy Type 1 : 2014-04-11 : Behavioral: Behavioural change intervention The intervention is cognitive behaviour therapy (CBT). The C |
Completed |
: Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1) : Myotonic Dystrophy : 2005-10-03 : Drug: SomatoKine/IPLEX Cohort 1: self-administered subcute |